Drug Profile
RGH 478
Alternative Names: RGH-478Latest Information Update: 20 Jul 2015
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Class Analgesics
- Mechanism of Action Bradykinin B1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Musculoskeletal pain; Osteoarthritis
Most Recent Events
- 02 Aug 2011 Phase-II clinical trials in Osteoarthritis in Hungary (PO)
- 02 Aug 2011 Phase-II clinical trials in Pain in Hungary (PO)